Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have a brain lesion that brain scans suggest may be glioblastoma (a type of brain tumour), or whose glioblastoma may have come back
- People whose general health and ability to carry out daily activities falls within an acceptable range as rated by a doctor (confirm with trial site for specific details)
- People who have signed a consent form before any study-related procedures take place
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People who have a significant medical, neurological, psychiatric, or surgical condition that is not currently under control and that, in the lead doctor's opinion, could interfere with completing the study
- People who experience claustrophobia (discomfort or anxiety in enclosed spaces, such as a scanner)
- People with a known allergic or sensitivity reaction to the study imaging agent (FAPI), any of its ingredients, or to the type of dye used in MRI scans (gadolinium-based contrast agents)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 02.555.81.93
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To compare the FAPI uptake within the tumor using quantitative measures (SUVmax, SUVmean, and volume) with the uptake of other markers of local tumor aggressiveness such as amino-acid PET and MRI data.; To compare FAPI tumor uptake (SUVmax, SUVmean) with FAP expression based on anatomopathological analysis (Immunohistochemistry) from targeted brain biopsy samples or material from ablative surgery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.